2020 NIAID Omnibus Broad Agency Announcement
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2020-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Xequel Bio, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93021C00009 Federal contract award
Notice details come from SAM.gov. Updated .
About this opportunity
FIRSTSTRING RESEARCH, INC was awarded a $4,975,617 cost-plus-fixed-fee contract by the National Institute of Allergy and Infectious Diseases to advance the development of candidate medical countermeasures to reduce mortality and morbidity associated with exposure to radiation from a radiological or nuclear incident. Under the 2020 NIAID Omnibus Broad Agency Announcement Research Area 001, this contract will progress lead candidate MCMs toward FDA approval or licensure to mitigate or treat radiation induced injuries and improve survival following a radiological event.
Notice text
The National Institute of Allergy and Infectious Diseases has awarded a cost-plus-fixed-fee contract under the Omnibus Broad Agency Announcement, Research Area 001, titled "Development of Radiation/Nuclear Medical Countermeasures (MCMs)". The objective of this Research Area is to advance the development of candidate medical countermeasures (MCM) to reduce mortality and/or major morbidities associated with exposure to radiation from a radiological or nuclear incident. This Research Area will advance lead candidate MCMs toward eventual FDA approval or licensure to mitigate or treat radiation induced injuries and thereby improve survival following a radiological event. It is anticipated that candidate MCMs will enter the evaluation and development pathway at various stages, from early research to post marketing (for drugs or biologics that are already licensed or approved for other indications).
Awarded contract 75N93021C00009 to FIRSTSTRING RESEARCH, INC for 4975617.00 on 2021-03-15.
Notice history
| Notice | Type | Posted |
|---|---|---|
| 2020 NIAID Omnibus Broad Agency Announcement | Award Notice | |
| 2020 NIAID Omnibus Broad Agency Announcement | Award Notice | |
| This notice | Award Notice | |
| 2020 NIAID Omnibus Broad Agency Announcement | Award Notice | |
| 2020 NIAID Omnibus Broad Agency Announcement | Solicitation | |
| 2020 NIAID Omnibus Broad Agency Announcement | Pre-Solicitation |
6 of 11 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity